0000874015-17-000019.txt : 20170208 0000874015-17-000019.hdr.sgml : 20170208 20170208183223 ACCESSION NUMBER: 0000874015-17-000019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170206 FILED AS OF DATE: 20170208 DATE AS OF CHANGE: 20170208 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 FORMER COMPANY: FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'NEIL PATRICK R. CENTRAL INDEX KEY: 0001564926 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 17583875 MAIL ADDRESS: STREET 1: C/O ISIS PHARMACEUTICALS, INC. STREET 2: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2017-02-06 0000874015 IONIS PHARMACEUTICALS INC IONS 0001564926 O'NEIL PATRICK R. C/O IONIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010 0 1 0 0 SVP, Legal & General Counsel Common Stock 2017-02-06 2017-02-06 4 S 0 1000 46.004 D 12449 D Common Stock 2017-02-06 2017-02-06 4 M 0 19 7.25 A 12468 D Common Stock 2017-02-06 2017-02-06 4 S 0 19 46.50 D 12449 D Common Stock 2017-02-06 2017-02-06 4 M 0 481 10.82 A 12930 D Common Stock 2017-02-06 2017-02-06 4 S 0 481 46.50 D 12449 D Employee Stock Option (right to buy) 7.25 2017-02-06 2017-02-06 4 M 0 19 0 D 2016-01-03 2019-01-02 Common Stock 19 1200 D Employee Stock Option (right to buy) 10.82 2017-02-06 2017-02-06 4 M 0 481 0 D 2017-01-02 2020-01-01 Common Stock 481 4426 D The sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 1/6/2017. Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 1/6/2017. /s/Patrick R. O'Neil 2017-02-07